Article summary
The International Coalition of Medicines Regulatory Authorities (ICMRA) has discussed policy issues and regulatory requirements with global medicinal regulators via a virtual meeting held on 14 May 2020 in response to the coronavirus (COVID-19) pandemic. Members of the ICMRA were able to exchange information regarding the regulatory flexibilities and measures deployed in response to the outbreak, underlining their concerns for the uninterrupted supply of medicines and personal protective equipment. As treatments for coronavirus are being researched globally, the participants of the virtual meeting discussed clinical trials and the potential to accelerate the development and approval of potential vaccines.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial